PURPOSE: To report clinical features of amiodarone-induced optic neuropathy
and outline the differentiation of amiodarone optic neuropathy from nonart
eritic anterior ischemic optic neuropathy.
METHOD: We reviewed data from 73 patients reported to have developed an opt
ic neuropathy while taking amiodarone
RESULTS: Amiodarone optic neuropathy is characterized by an insidious onset
, slow progression, bilateral visual loss, and protracted disk swelling tha
t tends to stabilize within several months of discontinuing the medication.
Nonarteritic ischemic optic neuropathy is characterized by acute, unilater
al visual loss that is usually complete at onset, with resolution of disk e
dema over several weeks.
CONCLUSION: Unique clinical features of amiodarone-induced optic neuropathy
may help clinicians diagnose and distinguish between amiodarone induced op
tic neuropathy and nonarteritic anterior ischemic optic neuropathy. (C) 199
9 by Elsevier Science Inc. All rights reserved.